AK Medical Holdings Limited (HKG:1789)

Market Cap	6.53B +3.7%
Revenue (ttm)	1.65B +10.1%
Net Income	377.35M +23.8%
EPS	0.34 +24.2%
Shares Out	1.12B
PE Ratio	17.35
Forward PE	14.19
Dividend	0.12 (2.02%)
Ex-Dividend Date	Jun 23, 2026

Volume	8,136,445
Open	5.86
Previous Close	5.85
Day's Range	5.80 - 6.07
52-Week Range	5.20 - 7.24
Beta	-0.35
Analysts	Strong Buy
Price Target	8.12 (+38.8%)
Earnings Date	Jun 3, 2026

About AK Medical Holdings

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products in the People’s Republic of China, the United Kingdom, and internationally. It offers knee, hip, and spinal and trauma replacement implants; and 3D-printed products, such as 3D-printed hip and knee replacement implants, 3D-printed spinal and trauma implants, as well as customized joint, pelvic, spinal and trauma implant products and customized value-added surgical services and orthopedic surgical ro...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 983
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1789

Financial Performance

In 2025, AK Medical Holdings's revenue was 1.48 billion, an increase of 10.11% compared to the previous year's 1.35 billion. Earnings were 339.09 million, an increase of 23.79%.

Financial numbers in CNY